#NVAX "announced that Gregory M. Glenn, M.D, President of Research & Development, will present on NVX-CoV2373, the Company’s COVID-19 vaccine, at the 2020 World Vaccine Congress Europe. The Congress takes place virtually October 19 - 21, 2020" (see press release HERE).
Presentation Title:Recombinant nanoparticle COVID-19 vaccine: Platform technology for Emerging Infectious Diseases (EID)Time:14:10 CET/8:10 am ET
For more information on the Congress or to register, please click here.
See our NVAX AmpCard to learn more.